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Thymic T cell development is characterized by sequential selection processes to ensure generation of a
self-tolerant, immuncompetent mature T cell repertoire. Malfunction of any of these selection
processes may potentially result in either immunodeﬁciency or autoimmunity. Myasthenia gravis (MG)
is a typical autoimmune manifestation of thymic epithelial tumors (thymomas) and is related to the
capacity of these tumors to generate and export mature T cells. Analysis of the factors that lead to
autoimmunization in thymomas will help to understand the mechanisms that prevent MG under
physiological conditions inhumans. In a comparison of MG(þ) and MG(2) thymomas, we could show
that only thymomas capable of generating mature CD45RAþCD4þ T cells are associated with MG
ðp , 0:0001Þ; while terminal thymopoiesis was abrogated in MG(2) thymomas. In particular,
acquisition of the CD27þCD45RAþ phenotype appears to be a critical checkpoint of late T cell
development in the human thymus and may play an important role in the prevention of autoimmunity.
Moreover, MG(2) thymomas were virtually depleted of regulatory (CD4þCD25þ) T cells (regT),
while regT were readily detectable in MG(þ) thymomas, albeit at signiﬁcantly reduced numbers
compared to control thymuses. Thus, in MG(þ) thymoma patients, thymectomy apparently also results
in removal of a regulatory T cell pool and may explain the frequent temporary postoperative
deterioration of MG in these patients.
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INTRODUCTION
Myasthenia gravis (MG) is an autoimmune disease
mediated by anti-acetylcholine receptor autoantibodies
that cause muscle weakness by impairing neuromuscular
transmission (Lindstrom et al., 1998). In a vast majority of
MG patients, the thymus shows pathologic alterations that
are believed to be aetiologically relevant for the disease.
In a subgroup of patients, MG is a paraneoplastic
manifestation of a thymic epithelial neoplasm (thymoma).
The current WHO classiﬁcation recognizes ﬁve MG-
associated histological thymoma subtypes, that reﬂect not
only morphological, but also functional and clinical
differences among the different types. Among these, type
AB, B2 and B3 thymomas are by far the most frequent
subtypes and at the same time show the highest
association with MG (Rosai, 1999; Muller-Hermelink
and Marx, 2000). Importantly, MG-associated thymomas
retain many functional features of the normal thymus,
namely the capacity to generate and export mature T cells
from immature precursors. However, no systematic
differences that allow to distinguish between MG(þ)
and MG(2) thymomas have been identiﬁed so far with
respect to T cell maturation. We and others have reported
on impaired maturation almost exclusively of the CD4
lineage, while development of the CD8 lineage is better
preserved (Nenninger et al., 1998; Strobel et al., 2001).
Furthermore, all known thymocyte maturation stages in
terms of CD3, CD69, CD4 and CD8 expression can be
detected in virtually all MG(þ) and MG(2) thymomas
(Takeuchi et al., 1995; Nenninger et al., 1998). Recently,
the introduction of measurement of so-called T cell
receptor (TCR) rearrangement excision circles (TRECS)
has allowed for the quantiﬁcation of naive T cells and thus
to directly assess the contribution of the thymus and
supposedly the thymoma to the peripheral T cell pool
(Douek et al., 1998). Buckley et al. reported on
abnormally increased numbers of naı ¨ve CD4þ and
CD8þ T cells in the blood of MG(þ) thymoma patients,
while an increase only of naı ¨ve CD8þ T cells was
detected in the blood of three MG(2) thymoma patients
(Buckley et al., 2001). This study suggested a role of
thymoma-derived CD4þ T cells in the pathogenesis of
paraneoplastic MG. However, it did not resolve the
underlying pathophysiology at the level of intratumorous
thymopoiesis. To address these questions, we analyzed
the intratumorous generation of mature naive CD45RAþ
thymocyte subsets (Vanhecke et al., 1995) in thymomas
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was studied using TUNEL assays.
Our results show that presence of paraneoplastic MG
is highly correlated with the efﬁciency of thymomas
to produce and export mature naı ¨ve CD4 T cells.
The transition from the CD27þCD45RA2 to the
CD27þCD45RAþ stage appears to be a critical
checkpoint in terminal thymocyte maturation not only in
thymomas, but also in the normal thymus. Efﬁcient
deletion at this stage may be an important mechanism of
central tolerance and in the prevention of autoimmunity.
MATERIALS AND METHODS
Patients
The clinical data of the patients and control persons
included in this study are summarized in Table I. Blood
samples were taken at time of thymectomy. Only patients
without steroid or immunsuppressive treatment prior to
surgery were included in this study. The diagnosis of MG
was based on clinical features, decrement testing on 3Hz
serial stimulation, and the detection of anti-AChR
antibodies as described previously (Nenninger et al.,
1998). All MG(þ) patients were autoantibody positive.
Tumors and Cell Preparation
Thymomas were classiﬁed according to the WHO
classiﬁcation (Rosai, 1999).
Thirteen non-neoplastic thymuses with inﬂammatory
changes (thymic lymphofollicular hyperplasia, TFH) were
used as controls for the thymic compartment. Prior to
staining for FACS analysis (see below), thymocytes and
PBMNC from all samples were isolated by Ficoll-
Hypaque density gradient centrifugation as described in
detail previously (Nenninger et al., 1998).
Nomenclature of Naı ¨ve Thymocyte- and T Cell Subsets
Thymocytes expressing either CD4 or CD8 together with
CD3, CD69, CD27 and CD45 RA were designated as
“mature naı ¨ve CD4 or CD8 T cells”, respectively.
Flow Cytometry
Sampling and data analyses of thymocytes and PBMNC
were performed on a FACScan ﬂow cytometer with Lysis
II software (Becton Dickinson, Heidelberg, Germany) as
described (Nenninger et al., 1998). The CD3þ T-cell
subset was gated for all analyses. 2 £ 105 cells were
stained for 3-colour FACS analysis with a panel of surface
antigen-directed monoclonal antibodies (mAbs) as
described previously (Nenninger et al., 1998). The panel
of antibodies included anti-CD3 labeled either with FITC
(Sigma, Deisenhofen, Germany), PE (Dako, Hamburg,
Germany) or TRI (Medac, Hamburg, Germany), anti-CD4
labeled with either PE or TRI, anti-CD8-PE (Dako); anti-
CD69 (either FITC-or PE-labeled) (Becton-Dickinson);
anti-CD27-PE (Pelicluster, Netherlands), CD45RO and
anti-CD45RA (either FITC- or PE-labeled) (Dianova,
Hamburg, Germany). Isotype controls were purchased
from Sigma and Medac.
TUNEL Assay
Thymocytes isolated from thymomas and from non-
neoplastic control thymuses were analyzed using a
commercially available TUNEL-kit (Boehringer,
Germany) according to the manufacturer’s instructions.
Prior to TUNEL labeling, cells were ﬁxed and
permeabilized using Cytoﬁx/Cytoperm solution and
Perm/Wash buffer (Pharmingen, Germany).
Statistical Analyses
All statistical analyses were performed using Chi-Square
and Man-Whitney-U test (p-value , 0:05; unless other-
wise indicated) provided by the SPSS software (Version
2000, SPSS Inc., Chicago, U.S.). In all column graphs
shown, the statistical mean ^ standard error of the mean
are depicted.
RESULTS
Acquisition of the Mature Naive
CD41CD271CD45RA1 Phenotype is a Critical
Checkpoint in Terminal Thymocyte Maturation
We and others have previously reported on impaired early
T cell development in different thymoma subtypes
(Takeuchi et al., 1995; Nenninger et al., 1998; Strobel
et al., 2001). Analyzing terminal T cell maturation in
13 non-neoplastic control thymuses, the population size of
CD4þ T cells was cut down by 50–60% at the transition
from the CD27þCD45RA2 to the CD27þCD45RAþ
TABLE I Clinical data of thymoma patients and control persons
Patient Number WHO thymoma subtype Sex Age (years) MG
1–9 2 AB; 7 B2/B3 6 F, 3 M 39–75 yes
10–22 6 AB; 7 B2/B3 7 F, 6 M 39–70 no
Controls
Thymus;n ¼ 13 TFH 10 F, 3 M 8–37 yes
TFH, thymic follicular hyperplasia.
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particularly of the histological subtypes B2 and B3, in
which the earlier steps of T cell maturation appear to be
largely undisturbed (Strobel et al., 2001). By contrast, the
proportion of CD4þCD27þCD45RAþ T cells was
highly signiﬁcantly reduced in all MG(2) thymomas
analyzed compared to both MG(þ) thymomas and control
thymuses (4:3 ^ 2:0 in MG(2) thymomas vs. 24:4 ^
18:9 in MG(þ) thymomas, p , 0:0001; Fig. 1). Thus, on
Chi-Square-test, presence of MG was signiﬁcantly linked
to high levels of mature naı ¨ve CD4þ T cells ðp , 0:01Þ:
Preliminary results of a TUNEL analysis showed that the
subtotal loss of the mature naive CD4 T cell subset is due
to deletion/apoptosis (Fig. 2). A subset of both MG(þ)
and MG(2) thymomas also showed a striking reduction of
mature naive CD8þ cells.
Together, these data point to the action of negatively
selecting mechanisms at the transition from the
CD27þCD45RA2 to the CD27þCD45RAþ mature
naive phenotype. Inefﬁciency of these negatively
selecting mechanisms (as indicated by obviously
permissive negative selection of CD4 cells in MG(þ)
thymomas) may cause break of central tolerance.
Regulatory (CD41CD251) T Cells are Highly
Reduced in Thymomas
In recent years, a speciﬁc CD25þCD4þ T cell
subpopulation with regulatory functions (regulatory T
cells, regT) has been identiﬁed in the thymus of both mice
and humans (Itoh et al., 1999; Stephens et al., 2001).
Thymus-derived regT are believed to be generated by
high-afﬁnity interactions with self-peptides present in the
thymus (Jordan et al., 2001). Several studies showed that
regT cells play an important role in controlling organ-
speciﬁc autoimmunity (Roncarolo and Levings, 2000;
Sakaguchi et al., 2001; Shevach et al., 2001). In a
comparison of MG(þ) and MG(2) thymomas with
control thymuses, we found a statistically signiﬁcant
5-fold reduction of regT cells in all thymomas irrespective
of presence or absence of MG (p , 0:05; Fig. 3), although
reduction of regT cells was more pronounced in MG(2)
thymomas.
DISCUSSION
In contrast to the well characterized early steps in
thymocyte maturation (Berg and Kang, 2001; Hogquist,
2001; MacDonald et al., 2001), the mechanisms control-
ling the late phase of thymopoiesis are poorly character-
ized. The crucial role of negative selection (i.e.
elimination of the majority of autoreactive thymocytes)
in the prevention of autoimmunity is a scientiﬁc paradigm
established by many experimental models (Laufer et al.,
1996; 1999; Naquet et al., 1999; Rubin and Kretz-
Rommel, 2001). Earlier studies on terminal thymopoiesis
in humans suggest (a) that late T cell development is an
MHC-independent process (Vanhecke et al., 1997) and
(b) that it occurs after acquisition of CD27 (Vanhecke
et al., 1995). CD27 is a member of the tumor necrosis
factor receptor (TNFR) family with pro-apoptotic proper-
ties (Prasad et al., 1997), its ligand, CD70, has been
identiﬁed on medullary thymic stromal cells (Hintzen
et al., 1995).
In this article, we provide evidence that the
transition from the CD4þCD27þCD45RA2 to the
CD4þCD27þCD45RAþ stage is a major negative
FIGURE 1 The percentage of mature naı ¨ve CD4 T cells is highly reduced in MG(2) thymomas. FACS analysis of naı ¨ve thymocyte subsets shows a
marked, statistically signiﬁcant reduction of CD4þCD27þ and of mature naive CD4þCD45RAþ T cells in MG(2) thymomas compared both to
MG(þ) thymomas and non-neoplastic control thymuses.
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T cell repertoire in humans. In control thymuses, the
percentage of thymocytes dropped by 70% between these
two stages. A similar reduction was detected in MG(þ)
thymomas, especially of the (cortical) WHO subtypes B2
and B3. MG(2) thymomas, by contrast, showed a subtotal
loss of CD4þCD27þCD45RAþ cells. TUNEL assays
showed that the number of CD4þCD27þ apoptotic cells
at this stage was increased compared to MG(þ)
thymomas, indicating that pro-apoptotic events prevented
the development of MG in these patients. Our results are in
good agreement with earlier observations that MG(þ),
but not MG(2) thymomas are enriched for autoreactive
T-cells (Sommeret al., 1990; Hoffacker et al.,2000), since
only terminally mature CD4þ thymocytes can signiﬁ-
cantly proliferate after T-cell receptor-mediated signalling
(van Hecke et al., 1995).
In the second part of the investigation, we asked
whether the observed differences in thymopoiesis between
MG(þ) and MG(2) thymomas were also pertinent to the
CD4þ T cell subset with regulatory functions (regT),
since it has been shown that the thymus has the ability to
generate regT cells from autoreactive T cells simul-
taneously with negative selection (Jordan et al., 2001;
Kawahata et al., 2002). In line with published data
(Stephens et al., 2001), we found CD25 expressed on
approximately 10% of CD4þCD82 T cells in control
thymuses. By contrast, the percentage of regT cells was
statistically signiﬁcantly reduced in thymomas with only
about 3% regT cells in MG(þ) thymomas and about 1.3%
in MG(2) thymomas (Fig. 3). Interestingly, the
percentage of regT cells was strongly reduced also in
MG(þ) type B2 and B3 (cortical) thymomas, in which
terminal thymopoiesis appeared otherwise undisturbed
(Fig. 1). This ﬁnding indicates that the T cell-stromal
interactions that lead to the production of regT cells under
physiologic conditions may be disturbed or even missing
in thymomas. In thymomas, reduced numbers of regT
cells on the one hand are accompanied by increased
numbers of autoreactive T cells on the other (Nenninger
et al., 1998). It is therefore tempting to speculate that there
may be a critical balance between regT and autoreactive
FIGURE 2 Apoptosis of CD4þCD27þ thymocytes is increased in MG(2) thymomas comparedto MG(þ) thymomas.RepresentativeFACS/TUNEL
analysis of a MG(þ) and a MG(2)WHO type B2 thymoma showing a signiﬁcant increase in apoptosis of CD4þCD27þ thymocytes. These ﬁndings
argue in favour of negative selection/deletion and against precocious release of immature thymocytes from the thymoma.
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lead to autoimmunity (Fig. 4). Our ﬁndings may explain
why paraneoplastic MG often deteriorates after thymoma
resection (Somnier, 1994; Beeson et al., 1998), since
removal of the tumor also implies removal of the small
“thymoma-speciﬁc” regT cell pool. In MG patients, these
regT cells are obviously not sufﬁcient to control
autoimmunity, but the clinical course of MG after
FIGURE 4 Potential consequences of reduced generation of regulatory T cells in the pathogenesis of MG. In the normal thymus, there may be a critical
balance between generation of autoreactive and regulatory T cells. Under normal conditions, thymic generation and export of regulatory T cells may
sufﬁce to control the few autoreactive T cells present in the blood also of healthy subjects. In thymomas, however, this balance is disturbed by increased
numbers of autoreactive T cells and decreased numbers of regulatory T cells. This imbalance may be a contributing factor in breaking peripheral
tolerance and in the pathogenesis of autoimmunity.
FIGURE 3 Generation of mature T cells with a regulatory (CD4þCD25þ) phenotype is highly reduced in thymomas. FACS analysis of 9 MG(þ) and
13 MG(2) thymomas as well as 13 non-neoplastic control thymuses showing a statistically signiﬁcant reduction of CD4þCD25þ regulatory T cells in
both MG(þ) and MG(2) thymomas, although reduction of this T cell subset was more pronounced in MG(2) tumors.
PARANEOPLASTIC MYASTHENIA GRAVIS 11thymoma resection may indicate that thymoma-derived
regT cells indeed have “suppressor” functions.
In summary, we used MG(þ) and MG(2) thymomas as
powerful human models for the identiﬁcation of the
mechanisms that regulate thymopoiesis and prevent
autoimmunity under normal conditions. Our ﬁndings
indicate that insufﬁcient negative selection may be a
pivotal factor in the pathogenesis of MG not only in
thymomas, but also in non-neoplastic thymuses with TFH.
Moreover, our results highlight the central role of
thymoma-derived CD4þ T cells in the pathogenesis of
paraneoplastic MG.
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